CNO Financial Group Set to Join the S&P MidCap 400
Get Alerts CNO Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.7%
EPS Growth %: +13.8%
Join SI Premium – FREE
NEW YORK, April 1, 2015 /PRNewswire/ -- CNO Financial Group (NYSE: CNO) will replace Salix Pharmaceuticals (NASD: SLXP) in the S&P MidCap 400 after the close of trading on Monday, April 6. Valeant Pharmaceuticals (NYSE: VRX) completed the acquisition of Salix Pharmaceuticals earlier today.
CNO Financial Group is a holding company that sells insurance throughout the US. Headquartered in Carmel, Indiana, the company will be added to the S&P MidCap 400 GICS (Global Industry Classification Standard) Life & Health Insurance Sub-Industry index.
Following is a summary of the change:
|
S&P MidCap 400 INDEX – April 6, 2015 | |||
|
COMPANY |
GICS ECONOMIC SECTOR |
GICS SUB-INDUSTRY | |
|
ADDED |
CNO Financial Group |
Financials |
Life & Health Insurance |
|
DELETED |
Salix Pharmaceuticals |
Health Care |
Pharmaceuticals |
Additions to and deletions from S&P Dow Jones Indices do not in any way reflect an opinion on the investment merits of the companies involved.
About S&P Dow Jones Indices
S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is the world's largest, global resource for index-based concepts, data and research. Home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®, S&P Dow Jones Indices LLC has over 115 years of experience constructing innovative and transparent solutions that fulfill the needs of investors. More assets are invested in products based upon our indices than any other provider in the world. With over 1,000,000 indices covering a wide range of asset classes across the globe, S&P Dow Jones Indices LLC defines the way investors measure and trade the markets. To learn more about our company, please visit www.spdji.com.
S&P® is a registered trademark of Standard & Poor's Financial Services LLC ("S&P"), a part of McGraw Hill Financial. Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"). These trademarks have been licensed to S&P Dow Jones Indices LLC. It is not possible to invest directly in an index. S&P Dow Jones Indices LLC, Dow Jones, S&P and their respective affiliates (collectively "S&P Dow Jones Indices") do not sponsor, endorse, sell, or promote any investment fund or other investment vehicle that is offered by third parties and that seeks to provide an investment return based on the performance of any index. This document does not constitute an offer of services in jurisdictions where S&P Dow Jones Indices does not have the necessary licenses. S&P Dow Jones Indices receives compensation in connection with licensing its indices to third parties.
For more information:
David BlitzerManaging Director and Chairman of the Index CommitteeS&P Dow Jones Indices(+1) 212 438 3907[email protected]
David R. GuarinoCommunicationsS&P Dow Jones Indices(+1) 212 438 1471[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cno-financial-group-set-to-join-the-sp-midcap-400-300059792.html
SOURCE S&P Dow Jones Indices
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Penguin Solutions Announces Closing of Oversubscribed Convertible Notes Offering
- Ontario Superior Court Awards Over $170 Million in Damages to Mutual Fund Investors in Landmark Class Action Decision
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share